News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication Jan 3, 2022 A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn’s Disease Read Now
Publication Dec 24, 2021 A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn’s Disease Read Now
Publication Nov 25, 2021 Systematic review: disease activity indices for immune checkpoint inhibitor-associated enterocolitis Read Now
Publication Sep 27, 2021 Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn’s Disease Clinical Trials Read Now
Publication Sep 14, 2021 Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis Read Now
Publication Jul 6, 2021 Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS) Read Now
